Consider two seemingly unrelated medical puzzles. First: Every day, our bodies produce hundreds of billions of new cells, many of which are mutated. If cancer arises from cellular mutation, why don't ...
When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment ...
Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...
When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment ...
Neurons generated from stem cells (from skin fibroblasts) of a patient with sporadic Alzheimer’s disease. Visualized with a specific green fluorescent marker. Nuclei are shown in blue. Researchers ...
GRIN Therapeutics' initiates pivotal phase 3 Beeline study of radiprodil for GRIN-related neurodevelopmental disorder: New York Tuesday, May 5, 2026, 17:00 Hrs [IST] GRIN Therapeu ...
Morning Overview on MSN
Researchers identify brain cell death switch that may worsen Alzheimer’s
Most neurons that die in Alzheimer’s disease do not simply starve or get smothered by amyloid plaques. According to a study published in April 2025 in Molecular Psychiatry, they may be destroyed from ...
Morning Overview on MSN
MIT discovers 30% of your brain’s synapses are 'silent' — dormant connections waiting until you need to learn something new
Picture every synapse in your brain as a phone line. About 70% of them are live, carrying signals right now. But according to ...
AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results